Journal Article Summary
The article investigates the effects of maternal levothyroxine (L-T4) use during pregnancy on the birth and neurodevelopmental outcomes of children. This topic is significant because thyroid disorders are common during pregnancy, and proper management is crucial for both maternal and fetal health. Understanding how L-T4 treatment impacts offspring can help inform guidelines for pregnant women with thyroid issues, ensuring both safety and optimal development for their children.
The study analyzed data from over 400,000 mother-child pairs in Hong Kong, focusing on those whose mothers were treated with L-T4 during pregnancy. The researchers found that children born to mothers using L-T4 had a higher risk of preterm birth compared to those born to mothers without thyroid issues. However, there was no significant association between L-T4 use and the risks of being small for gestational age, or developing attention-deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
Despite its findings, the study has limitations, including the inability to account for all potential confounding factors, such as maternal socioeconomic status and medication adherence. It also did not differentiate between spontaneous and medically indicated preterm births. Patients should discuss their thyroid treatment with healthcare professionals, considering the potential risks and benefits of L-T4 during pregnancy, and ensure that their thyroid function is monitored closely to support both maternal and fetal health.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Ge Grace Mengqin, Cheung Edmund C. L., Man Kenneth K. C., Ip Patrick, Leung Wing Cheong, Li Gloria H. Y., Kung Annie W. C., Cheung Ching-Lung, et al.. Association of maternal levothyroxine use during pregnancy with offspring birth and neurodevelopmental outcomes: a population-based cohort study. BMC Medicine 2022. DOI: 10.1186/s12916-022-02586-9. PMID: 36344981. PMCID: PMC9641874.
Featured Pill Pals Product
Levothyroxine 88 mcg Tablets --- Generic For Synthroid --- Accord
Levothyroxine 88 mcg Tablets — Generic For Synthroid — Accord is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
